468 results on '"Fürst S"'
Search Results
2. Spinal ataxia due to cervical cord compression caused by a melanoma in the extradural atlanto-occipital neck region in anataxic pony
3. CAR-T cells : lymphocytes exprimant un récepteur chimérique à l’antigène
4. 3-D GRMHD and GRPIC Simulations of Disk-Jet Coupling and Emission
5. Principal component analysis of the X-ray variability in NGC 7469
6. 3-D GRMHD Simulations of Disk-Jet Coupling and Emission
7. The nature and origin of Seyfert warm absorbers
8. Editorial
9. THE INFLUENCE OF OBESITY ON TUMOR RECURRENCE IN VULVAR CANCER PATIENTS: EP1168
10. Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients
11. Characterization of different types of silicon photomultipliers for PET: A study using optical photon tracking simulations and measurements
12. AUTOSAR als DIE Software Plattform für intelligente Mobilität /AUTOSAR proofs to be THE automotive software platform for intelligent mobility
13. T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes
14. Das Therapieansprechen auf systemische Kortikosteroide bei Patienten mit aktiver Colitis ulcerosa ist mit der Regeneration des Mikrobioms und erhöhter mikrobielle Butyratproduktion assoziiert
15. P1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WHO UNDERWENT PERIPHERAL BLOOD HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OR HIGH RISK MYELODYSPLASTIC SYNDROME
16. Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients
17. Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
18. Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML
19. Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning
20. Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT
21. TLI in refractory chronic GVHD
22. Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin’s lymphoma
23. Goldobjekte und Goldgruppen – Untersuchungen und Analysen zum latènezeitlichen Goldfingerring von Nackenheim, Lkr. Mainz-Bingen
24. The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT
25. PET/MRT in der Diagnostik gastrointestinaler Tumoren
26. Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
27. A RETROSPECTIVE MONOCENTRIC ANALYSIS OF RELATED DONORS WHO UNDERWENT BONE MARROW COLLECTION FOLLOWING MOBILZATION/COLLECTION FAILURE: PH-AB180
28. Outcome parameters in node-negative vulvar cancer - a subset analysis of the AGO CaRE-1 study: ID 329
29. AGO Vulva CaRE-1 multicenter study - adjuvant radio(chemo)therapy in vulvar cancer: ID 244
30. Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
31. High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
32. Greffe de cellules souches hématopoïétiques après conditionnement atténué dans les leucémies aiguës myéloblastiques: Allogreffe après RIC pour LAM
33. Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)
34. Effects of Structural Modifications of N-CPM-Normorphine Derivatives on Agonist and Antagonist Activities in Isolated Organs
35. Post-transplantation cyclophosphamide is safe and effective to prevent immunological reaction after unmanipulated haploidentical bone marrow transplantation following nonmyeloablative conditioning for advanced lymphomas: 109
36. Improved method for the isolation, characterization and examination of neuromuscular and toxic properties of selected polypeptide fractions from the crude venom of the Taiwan cobra Naja naja atra
37. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids
38. Disease status but not histology is predictive of outcome in lymphoma patients after allogeneic stem cell transplantation with reduced-intensity conditioning regimen: P1064
39. Reduced-intensity conditioning (and not nonmyeloablative) conditioning in patients older than 55 years: a phase 2 multi-centre study of allogeneic stem cell transplantation from matched related donor: O283
40. Rolle der Makrophagendifferenzierung und -interaktion mit regulatorischen T-Zellen bei der Progression und Regression der HPV-induzierten Zervixdysplasie
41. Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison
42. Beyond the News Media Logic? Analyzing the Social Media Orientation of University Leadership
43. Characterization of allorestricted T cell receptors (TCR) with specificity for FMNL1 and HER2/neu for potential clinical application: V332
44. Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning
45. Rituximab as salvage therapy for refractory chronic GVHD
46. Chromatographic investigation and computer simulation of L-deprenyl metabolism
47. Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation
48. Rituximab as salvage therapy for refractory chronic GVHD
49. Reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukaemia: long-term results of a "donor" versus "no donor" comparison
50. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies - A Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.